仟源医药股价下跌4.48% 上半年净利润同比下滑98.86%

Group 1 - The stock price of Qianyuan Pharmaceutical on August 26 was 11.51 yuan, down 0.54 yuan or 4.48% from the previous trading day [1] - The company operates in the chemical pharmaceutical sector, focusing on the research, production, and sales of pharmaceuticals and health foods, as well as medical diagnostics and genetic preservation services [1] - In the first half of 2025, the company reported revenue of 373 million yuan, a year-on-year decrease of 7.01%, and a net profit attributable to shareholders of 380,900 yuan, down 98.86% year-on-year [1] Group 2 - The company's net loss from non-recurring items was 5.01 million yuan, primarily due to the impact of a subsidiary's payment of corporate income tax and late fees [1] - On August 26, the net outflow of main funds for Qianyuan Pharmaceutical was 57.33 million yuan, accounting for 2.19% of the circulating market value [1] - Over the past five days, the net outflow of main funds totaled 128.93 million yuan, representing 4.93% of the circulating market value [1]